ETHYL (3S)-7-CHLORO-2,3-DIHYDRO-2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPINE-3-CARBOXYLATE
UNII FTZ6JH2EWP
Substance Identification & Data
This profile provides standardized clinical and technical data for Ethyl (3s)-7-chloro-2,3-dihydro-2-oxo-5-phenyl-1h-1,4-benzodiazepine-3-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FTZ6JH2EWP.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 353524-67-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H15ClN2O3 DTKOQJNQMOCKQU-INIZCTEOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Ethyl (3s)-7-chloro-2,3-dihydro-2-oxo-5-phenyl-1h-1,4-benzodiazepine-3-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.